Bristol-Myers Squibb (BMY) Stock Price Today & Analysis
BMY
Fundamental
Valuation
Market capN/A
Price-to-sales ratio2.32
Price-to-book value6.00
Price-earnings ratioN/A
Return on Equity30.00%
Return on Sales0.14%
Return on Assets0.05%
PEG ratioN/A
Earnings Per Share
Earnings Per ShareN/A
Income Statement
Average volumeN/A
EBITDA$13.07B
1 year high (52w)N/A
1 year low (52w)N/A
Dividend
Dividend yieldN/A
Solvency
Debt-to-equity ratioN/A
About Bristol-Myers Squibb
We are a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We work every day to transform patients’ lives through science. We combine the agility of a biotech with the reach and resources of an established pharmaceutical company to create a global leading biopharma company powered by talented individuals who drive scientific innovation.
FAQ
You can easily purchase Bristol-Myers Squibb (BMY) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'BMY' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in Bristol-Myers Squibb with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
